Jacob Mandel - Concepedia

Author

Jacob Mandel

Baylor College of Medicine ORCID

Also Known As

J. Mandel, Jacob J Mandel, Jacob J. Mandel, Jacob Joseph Mandel, Jacob Mandel, M. Mrugala, Mandel, Jacob

112

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Baylor College of Medicine The University of Texas MD Anderson Cancer Center Medical University of South Carolina Rabin Medical Center Tel Aviv University

About

Jacob Mandel is an author at Baylor College of Medicine specializing in medicine, neuro-oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	641
2	Health Sciences	3	3	88
3	Public Health	2	2	48
4	Engineering	1	1	11
5	Social Sciences	1	1	18

Jacob Mandel

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Federated learning enables big data for rare cancer boundary detection Sarthak Pati, Ujjwal Baid, Brandon Edwards, Nature Communications	2022	306
Factors Associated With Age Disparities Among Cancer Clinical Trial Participants Ethan B. Ludmir, W. Ian P. Mainwaring, Timothy A. Lin, JAMA Oncology	2019	212
Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages John de Groot, Marta Peñas-Prado, Kristin Alfaro-Munoz, Neuro-Oncology	2019	158
Neurologic complications of immune checkpoint inhibitors Avi Fellner, Chen Makranz, Michal Lotem, Journal of Neuro-Oncology Neurologic ComplicationsNeuro-oncologyMedicineImmunologyImmune Checkpoint Inhibitor	2018	154
Venous thromboembolism (VTE) and glioblastoma Shlomit Yust‐Katz, Jacob Mandel, Jimin Wu, Journal of Neuro-Oncology Pulmonary EmbolismThrombosisNeuro-oncologyVenous DiseaseVenous Thrombosis	2015	86
Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma Jacob Mandel, Shlomit Yust‐Katz, Akash J. Patel, Neuro-Oncology	2017	83
Primary and secondary gliosarcomas: clinical, molecular and survival characteristics David Cachia, Carlos Kamiya-Matsuoka, Jacob Mandel, Journal of Neuro-Oncology Tumoral PathologyMedicineBrain Tumor BiologyPathologyOncology	2015	75
Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution Jacob Mandel, Shlomit Yust‐Katz, David Cachia, Journal of Neuro-Oncology Neuro-oncologyMedicineNeurologyHigh-grade GliomasLeptomeningeal Dissemination	2014	73
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma Jacob Mandel, David Cachia, Diane Liu, Journal of Neuro-Oncology Neuro-oncologyTumor HeterogeneityMedicineClinical TrialsPathology	2016	49
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials Ethan B. Ludmir, Ishwaria M. Subbiah, W. Ian P. Mainwaring, Journal of Geriatric Oncology EpidemiologyPreventive MedicineCancer EpidemiologyHealth PolicyCancer Screening	2019	37

Page 1